The research team, funded by NASA and the USDA National Institute of Food and Agriculture, set out to test a long-standing hypothesis in space plant biology. Previous transcriptomic studies had shown that when plants are placed in low-pressure environments, hundreds of genes change their expression, including genes involved in cell wall biosynthesis and sugar transport. Genes encoding galacturonosyltransferases such as GAUT7, which build pectin backbones, and xyloglucan endo-transglycosylase/hydrolases such as XTH16, which remodel hemicellulose, were differentially expressed, as were sugar transporter genes of the SWEET family. On paper, that molecular activity suggested the cell wall might be physically altered by hypobaria. But gene expression is only a proxy. Until now, no one had directly measured the actual biochemical composition of cell walls from plants grown under low pressure, leaving a gap between molecular hints and material reality.

To close that gap, the researchers grew four genotypes of Arabidopsis thaliana, the standard workhorse of plant genetics: the wild-type accessions Columbia (Col-0) and Wassilewskija (Ws), plus two knockout mutants, pdc1 and sweet11, each disrupted in a gene previously implicated in the hypobaric response. The seedlings were raised vertically in sterile culture for ten days under constant light at 23 degrees Celsius, then subjected to three-day pressure treatments in a trio of interconnected polycarbonate chambers with a combined interior volume of roughly 7,500 cubic centimeters. A vacuum controller held the chambers at target pressures of 75, 50, or 33 kilopascals, with 98 kilopascals serving as the sea-level control. Because the atmospheric composition was not artificially manipulated, reducing total pressure also reduced the partial pressure of oxygen, creating combined hypobaric-hypoxic conditions with oxygen partial pressures of approximately 16, 10.7, and 7 kilopascals respectively.

The choice of 33 kilopascals was deliberate and dramatic. That figure approximates the total atmospheric pressure at the peak of Mount Everest, some 8,847 meters above sea level, and sits well below the roughly 47 kilopascals that appears to mark the natural altitudinal limit of terrestrial plant life. It also falls far outside the 55 to 65 kilopascals proposed for future spacecraft cabins. In other words, the seedlings were pushed beyond anything in the evolutionary experience of lowland crop plants, into a regime that exists on Earth only at the planet’s most extreme elevations, and even there only briefly and in combination with cold, drought, and intense ultraviolet radiation.

The morphological results were sobering but expected. Seedlings grown at 33 kilopascals were visibly smaller and stunted compared with controls, and their shoots showed statistically significant reductions in fresh weight. This aligns with a broader literature on hypobaric plant physiology: lettuce grown at 25 kilopascals for ten days lost roughly 46 percent of its dry leaf weight in one study, and other work across monocots and dicots has documented mixed but recurring growth penalties under low pressure. The picture is complicated by the fact that hypobaria and hypoxia travel together when atmospheric composition is uncorrected, and previous experiments have shown that drought-like stress responses can be triggered by low pressure even when water is freely available. Disentangling those components remains an active area of research.

But the biochemical story turned out very differently. Using a technique called high-performance anion-exchange chromatography with pulsed amperometric detection, or HPAEC-PAD, the team quantified nine cell wall monosaccharides, including fucose, rhamnose, arabinose, galactose, glucose, xylose, mannose, galacturonic acid, and glucuronic acid, in both root and shoot tissues. The procedure involved extracting the alcohol insoluble residue from roughly 100 milligrams of frozen tissue, hydrolyzing the wall polysaccharides with 2 molar trifluoroacetic acid at 120 degrees Celsius for 90 minutes, and normalizing the released sugars against an internal ribose standard and an external calibration curve. The result across three independent experimental repetitions was strikingly uniform: no consistent differences in matrix polysaccharide composition attributable to pressure treatment, in either tissue type, at any of the tested pressures.

Equally notable was the behavior of the mutants. The sweet11 knockout was of particular interest because earlier work using Fourier transform infrared spectroscopy had suggested that disrupting SWEET11 and its relative SWEET12 could alter the abundance of acidic pectins and rhamnogalacturonans in the wall. Yet in this study, sweet11 showed no consistent differences in monosaccharide composition from its Col-0 wild type or from the Ws ecotype, at control pressure or under any hypobaric treatment. The pdc1 mutant, chosen because pyruvate decarboxylase 1 is reliably induced under both normoxic and hypoxic hypobaria and plays a central role in low-oxygen responses, likewise failed to diverge from wild type. Whatever roles these genes play in the hypobaric stress response, they do not appear to be required for maintaining the bulk monosaccharide composition of the cell wall matrix.

The authors are careful about what this resilience does and does not mean. The technique measures the overall abundance of constituent monosaccharides, not the fine structural organization of the polysaccharides, their degree of methylesterification or acetylation, or their cross-linking architecture. Subtle chemical modifications that would not show up in a monosaccharide profile remain unexplored. The experiments also covered only three days of exposure in young seedlings, so the effects of long-term hypobaria spanning a full life cycle, or of plants germinated and grown entirely under low pressure, are still unknown. And the fresh weight penalty at 33 kilopascals shows that resilience at the biochemical level does not translate into unimpaired growth under the most severe conditions tested.

Nevertheless, the study represents a genuine first: the earliest application of glycomic techniques to the question of how hypoxic hypobaric environments affect plant cell wall composition at the monosaccharide level. Its central conclusion, that the cell wall matrix of young Arabidopsis seedlings is resilient to hypobaric exposure, offers cautious encouragement for the designers of extraterrestrial greenhouses. The transcriptomic alarm bells that ring when plants encounter low pressure, it turns out, do not necessarily signal structural damage to the wall itself; they may reflect regulatory adjustments that successfully preserve wall composition. For mission planners weighing the trade-offs between cabin pressure and crop performance, that distinction matters. If the structural fabric of plant tissues holds steady at pressures relevant to proposed habitats, the engineering case for low-pressure agriculture in space grows stronger, even as the questions about long-term adaptation, wall architecture, and growth under sustained hypobaria keep the field busy for years to come.

Subject of Research: The biochemical resilience of plant cell wall matrix polysaccharides under hypobaric stress relevant to space agriculture

Article Title: Hypobaric Resilience of Matrix Polysaccharide Biosynthesis in Plants

Article References: Strickland, H. F., Jacobson, T., Smith, G., Voiniciuc, C., Schuerger, A. C., Paul, A.-L., & Ferl, R. (2026). Hypobaric Resilience of Matrix Polysaccharide Biosynthesis in Plants. Plant Direct, 10(10), Article e70190. https://doi.org/10.1002/pld3.70190

Image Credits: AI Generated

DOI: 10.1002/pld3.70190

Keywords: hypobaria, plant cell wall, Arabidopsis thaliana, space agriculture, bioregenerative life support, matrix polysaccharides, HPAEC-PAD, hypoxia, SWEET11, PDC1, spaceflight, glycomics

The timing of the study is significant. NASA is currently planning multiple missions with durations exceeding six months in space, spanning commercial activity in low Earth orbit, the Artemis IV mission that will carry the first crewed flight to the lunar south pole in 2028, and the development of sustainable surface capabilities on the moon in preparation for eventual human journeys to Mars. Each of these endeavors will demand more human participation and more cumulative time spent in extraterrestrial environments, and each will draw on crews selected precisely because of their exceptional physical fitness and optimal health. The paradox highlighted by the new research is that the very individuals best equipped to endure the rigors of spaceflight may nonetheless carry forward hidden skeletal vulnerabilities that standard post-flight assessments do not fully capture.

The underlying physiology is well established, even if its long-term consequences have been harder to quantify. Muscle and bone loss in the microgravity environment of space is a common physiologic phenomenon among astronauts, and it is understood as an adaptive response to disuse. In the absence of gravitational loading, the skeleton receives far less mechanical stimulation than it does on Earth, and the body responds by reducing bone formation while resorption continues, gradually eroding bone mass and altering the internal architecture of load-bearing structures such as the hip. What makes this process insidious, as lead investigator Jean D. Sibonga, PhD, of NASA’s Johnson Space Center has noted, is that humans do not feel the effects of bone loss. An astronaut can return from space, feel stable, and even believe themselves fully recovered, then resume physically demanding activities despite underlying skeletal changes caused by prolonged disuse.

That disconnect between how astronauts feel and what their bones can actually withstand is central to why the new findings matter. A better understanding of bone health after spaceflight, the researchers argue, could help astronauts, patients, and clinicians assess long-term health concerns, determine appropriate care, and reduce the risk of injury. The hip is a particularly consequential site in this regard. Hip fractures are among the most serious fragility fractures in any population, associated with substantial morbidity, long recovery periods, and elevated mortality risk, especially when they occur at ages earlier than typical. A fracture rate that rises after long-duration flight, and that emerges at younger ages than would be expected in the general terrestrial population, therefore represents a warning signal that extends well beyond the immediate post-mission period.

One of the persistent obstacles in spaceflight medicine has been the sheer difficulty of gathering statistically robust data. Matthew T. Drake, MD, PhD, of the Endocrinology and Metabolic Bone Disease Service at the Hospital for Special Surgery in New York, and co-author of an accompanying editorial in the same journal, observed that while data to date on bone loss associated with spaceflight are consistent, a major limitation is accuracy, because astronaut cohort sample sizes are small and spaceflights are rare. With only a few hundred people having ever flown in space, and only a subset of those undertaking missions longer than 90 days, conventional epidemiological comparisons often lack the statistical power to detect meaningful differences in fracture outcomes. Small cohorts and rare events make it easy for real effects to hide within the noise.

To overcome this statistical limitation, the investigators took a different analytical approach. They surveyed a cohort of US-based astronauts for all fractures reported during annual clinical exams, assembling a longitudinal record of skeletal outcomes across careers that spanned missions of varying lengths. They then analyzed these data using Bayesian probabilistic modeling, a framework that allows researchers to draw more stable inferences from small samples by incorporating prior knowledge and quantifying uncertainty explicitly. The results were striking in their specificity. While the study did not find a higher incidence rate for fractures in general, the incidence rate for hip fractures in astronauts was increased after a long-duration spaceflight of more than 90 days. The effect was not a diffuse elevation of injury risk across the skeleton, but a concentrated signal at one of the body’s most mechanically critical sites.

Two features of that signal stand out. First, the increased hip fracture rate occurred at a younger age than would be expected in a non-astronaut terrestrial population, meaning astronauts were experiencing these injuries earlier in life than standard fracture epidemiology would predict. Second, the rate was greater than the rate observed before a long-duration mission, or with no spaceflight exposure at all, which points to the spaceflight itself, rather than age or occupational hazards alone, as the differentiating factor. Moshe Gertzulin, MD, also of the Endocrinology and Metabolic Bone Disease Service at the Hospital for Special Surgery and co-author of the accompanying editorial, summarized the implication: taken together, the finding of hip fracture occurrence at an age earlier than expected after long-duration spaceflight is clinical evidence that spaceflight-induced bone loss can lead to real long-term fracture consequences, which should be addressed accordingly.

The study’s authors argue that these conclusions carry direct implications for how space agencies monitor skeletal health. Dr. Sibonga emphasized the need to expand NASA’s current bone surveillance program beyond dual-energy X-ray absorptiometry, or DXA, measurements of bone mineral density, the long-standing standard for assessing skeletal status. DXA provides a two-dimensional summary of density but offers limited insight into the three-dimensional structure of bone, which is increasingly recognized as a critical determinant of fracture resistance. NASA has recently begun ordering quantitative computed tomography scans before and after spaceflight, a modality that can provide more detailed information about different areas of the bone and about whether astronauts have truly fully recovered. Without that finer-grained insight, astronauts could risk placing too much strain on bones that have not yet regained their preflight condition, precisely the scenario in which a fragility fracture is most likely to occur.

Beyond surveillance, the investigators advocate for prophylactic countermeasures designed to preserve the baseline, pre-flight skeletal health of the astronaut, rather than attempting to reverse damage after the fact. A fuller characterization of spaceflight-induced changes to bone mass, density, structure, and microarchitecture will determine which interventions, whether pharmaceutical agents, exercise regimens, or dietary adjustments, are most beneficial for long-term skeletal health. Current in-flight countermeasures centered on resistive exercise have slowed but not fully prevented bone deterioration on long missions, and the new fracture data suggest that residual deficits matter over timescales of years, not weeks. Identifying the right combination of countermeasures before crews embark on months-long lunar surface stays and multi-year Mars transits could mean the difference between a mission that ends with healthy crews and one that seeds decades of orthopedic problems.

The broader significance of the study extends beyond the astronaut corps. The disuse-related bone loss that astronauts experience is, in essence, an accelerated model of the immobilization and unloading that affects patients on Earth, from those confined to bed rest to individuals with spinal cord injuries or age-related osteoporosis. Insights gained from studying spaceflight-induced skeletal changes, and from the advanced imaging and modeling techniques being deployed to study them, may inform how clinicians on Earth assess and manage fragility in their own patients. For now, the message from Mayo Clinic Proceedings is unambiguous: the skeleton keeps a record of every day spent in microgravity, and for missions longer than 90 days, that record includes a heightened risk of hip fracture that surfaces earlier in life than anyone would want. As humanity prepares to spend longer stretches of time on the moon and beyond, safeguarding the bones that carry astronauts home has become a scientific challenge worthy of the ambition of the missions themselves.

Subject of Research: Long-duration spaceflight-induced bone loss and hip fracture risk in astronauts

Article Title: Study links 90+-day spaceflights to higher rates of hip fractures in astronauts

Article References: Study links 90+-day spaceflights to higher rates of hip fractures in astronauts. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: astronauts, hip fracture, bone loss, microgravity, spaceflight, NASA, Mayo Clinic Proceedings, bone mineral density, quantitative computed tomography, osteoporosis, Artemis, space medicine

The research, published in the journal Microbiome, describes a 21-day continuous-occupation trial in which a student crew lived inside the ILMAH while researchers sampled surfaces across eight modules. Rather than simply cataloging all the DNA left behind on surfaces, the team, led by Haley O. Boles of the University of North Dakota and Kasthuri Venkateswaran of NASA’s Jet Propulsion Laboratory, used viability-targeted methods designed to distinguish living microorganisms from dead biomass, a distinction that matters enormously for assessing actual risk to crews on long-duration missions.

The technique at the heart of the study is propidium monoazide treatment combined with digital PCR, known as PMA-dPCR. Propidium monoazide is a DNA-binding dye that cannot penetrate intact cell membranes; it infiltrates only dead cells, where it binds DNA and prevents amplification. By applying the dye before quantifying 16S rRNA gene copies, the researchers effectively filtered their measurements down to organisms with intact, presumably viable, cells.

The results revealed dramatic spatial heterogeneity in viable bacterial loads, which ranged from 10^8 to 10^11 16S rRNA gene copies per square meter of surface. High-traffic modules, including the Entrance, Kitchen, Bathroom, and Crew Quarters, carried consistently higher burdens than low-traffic areas, with a difference of roughly 4.11 log units, a gap that was highly statistically significant. Fungal loads, by contrast, were far more uniform across the habitat and did not differ meaningfully by location, suggesting that fungi distribute themselves more evenly regardless of where crew members spend their time.

To corroborate the PMA-dPCR measurements, the team measured intracellular ATP, the energy-carrying molecule found in all living cells, which tracked closely with the viable cell counts across modules. Culture-based counts using ready-to-use dry-sheet culture media told a different story: they were two to three orders of magnitude lower than the viability-adjusted molecular estimates. That gap points to a substantial viable-but-nonculturable fraction, a well-known phenomenon in microbiology in which cells are alive and metabolically active but will not grow under standard laboratory conditions. In a habitat context, it means routine culturing alone would dramatically understate the living microbial burden surrounding a crew.

From the habitat’s surfaces, the researchers isolated and characterized 240 strains, 140 bacteria and 100 fungi, encompassing 42 bacterial and 26 fungal species. Among these were three putative novel fungal taxa, a reminder that even analog habitats on Earth can harbor microbes new to science. Amplicon sequencing of the 16S rRNA gene from PMA-treated samples showed that community structure was driven by location, dominated by the genus Pseudomonas, with episodic enrichment of Acinetobacter in the quieter, less-visited modules.

Shotgun metagenomic sequencing, which reads all genetic material in the samples rather than just a single marker gene, added functional depth. It confirmed strong spatial structuring of the viable microbiome: high-traffic modules were enriched in Pseudomonas, while low-traffic modules hosted greater fungal prevalence and higher taxonomic diversity. The functional potential of these communities followed the same geographic logic, with the busiest areas concentrating metabolic and survival machinery adapted to frequent disturbance and resource scarcity.

Perhaps the most consequential findings concern biosafety. Metagenomics detected low-abundance viable biosafety level-2 taxa, including Salmonella enterica and Serratia species, and revealed that antimicrobial resistance genes and virulence factor signatures were concentrated in the high-traffic modules, largely carried by Pseudomonads. The picture that emerges is not a random smear of contamination but a selectively filtered ecosystem in which the most resilient, potentially problematic organisms accumulate precisely where humans touch most often.

The authors conclude that the ILMAH supports a spatially differentiated, stress-tolerant core microbiome maintained by human occupancy and selective survival. Interestingly, the viability-based approach cuts both ways: while total DNA measurements can overestimate the diversity of living organisms by including fragments from dead cells, the community that does survive is low in richness yet high in resilience. In other words, sealed habitats select for a small cast of tough generalists rather than a wide array of species.

The practical implications reach well beyond spaceflight. The integrative workflow established in this study, combining PMA-dPCR, ATP measurement, culture, amplicon sequencing, and shotgun metagenomics, offers a template for biosurveillance in any sealed ecological system, from submarines and hospital isolation wards to deep-space transit vehicles. As agencies plan multi-year missions to Mars, knowing which microbes are alive, where they cluster, and what they can do may prove as important to crew health as monitoring radiation or air quality. This study provides the first rigorous, viability-aware baseline for that task.

Subject of Research: The viable microbial ecology and functional potential of the Integrated Lunar-Mars Analog Habitat, characterized using viability-targeted multi-omics analyses during a 21-day human occupation trial.

Article Title: Viable microbial ecology and functional potential of the Integrated Lunar-Mars Analog Habitat revealed by multi-omics analyses

Article References: Boles, H. O., Hernandez, E., Kahsen, J., Suzuki, T., Okochi, N., Jeon, T., Naik, S., Joshi, N., Tumeo, A., Lin, W.-J., Miliotis, G., de León, P., Green, S. J., & Venkateswaran, K. (2026). Viable microbial ecology and functional potential of the Integrated Lunar-Mars Analog Habitat revealed by multi-omics analyses. Microbiome. https://doi.org/10.1186/s40168-026-02516-4

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02516-4

Keywords: ILMAH, space microbiome, PMA-dPCR, metagenomics, Pseudomonas, antimicrobial resistance, viable but nonculturable, analog habitat, biosurveillance, spaceflight, 16S rRNA, ATP